Chronic kidney disease in patients with diabetes mellitus type 2 or hypertension in general practice

British Journal of General Practice

Volumn 60, Issue 581, 2010, Pages 884-890

  Van Der Meer, Victor ^a   Wielders, H Petra M ^b   Grootendorst, Diana C ^a   De Kanter, Joost S ^d   Sijpkens, Yvo W J ^c   Assendelft, Willem J J ^b   Gussekloo, Jacobijn ^b   Dekker, Friedo W ^a   Groeneveld, Ymte ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b General Practice ^*  (United States)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

^d Academic Primary Health Care Centre 'Stevenshof'   (Netherlands)

Author keywords

Diabetes; Hypertension; Kidney disease, chronic; Prevalence; Primary care; Screening

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN;

ADULT; AGE; AGED; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENDER; GENERAL PRACTICE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE;

ADULT; AGED; ALBUMINURIA; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGIC METHODS; FEMALE; GENERAL PRACTICE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NETHERLANDS; RENAL INSUFFICIENCY, CHRONIC;

EID: 78650576527     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp10X544041     Document Type: Article

References (22)

1. Hallan SI, Dahl K, Oien CM, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006; 333(7577): 1047-1052.
2. Keith DS, Nichols GA, Gullion CM, et al Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164(6): 659-663.
3. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med; 351(13): 1296-1305.
4. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 Suppl 1): S1-S266.
5. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2009; 32 Suppl 1: S13-S61.
6. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007; 14 Suppl 2: E1-40.
7. Richards N, Harris K, Whitfield M, et al. The impact of population-based identification of chronic kidney disease using estimated glomerular filtration rate (eGFR) reporting. Nephrol Dial Transplant 2008; 23(2): 556-561.
8. De Lusignan S, Chan T, Stevens P, et al. Identifying patients with chronic kidney disease from general practice computer records. Fam Pract 2005; 22(3): 234-241.
9. Nielen MMJ, Schellevis FG, Verheij RA, [Prevention of chronic kidney disease in primary care] in Dutch. Utrecht: NIVEL, 2006.
10. Lamberts H, Wood M. International classificatian of primary care. Oxford: Oxford University Press, 1987.
11. Levey AS, Corsh J, Balk E, et al. National Kidney Foundation practice guideline for chronic kidney disease: evaluation, classification, and stratification, Ann Intern Med 2003; 139(2): 137-147.
12. Viberti GC, Mogensen CE, Passa P, et al. St Vincent declaration: guidelines for the prevention of diabetic renal failure. In: Mogensen CE, ed. The kidney and hypertension in diabetes mellitus. Dordrecht: Kluwer Academic Publishers, 1994:515-527.
13. Ravera M, Noberasco G, Re M, et al. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. Nephrol Dial Transplant 2009; 24(5): 1528-1533.
14. Redón J, Cea-Calvo L, Lozano JV, et al. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study. ; Hypertens 2006; 24(4): 663-669.
15. Clase CM. Glomerular filtration rate: screening cannot be recommended on the basis of current knowledge. BMJ 2006; 333(7577): 1030-1031.
16. Brantsma AH, Bakker SJL, De Zeeuw D, et al. Extended prognostic value of urinary albumin excretion for cardiovascular events. J Am Soc Nephrol 2008; 19(9): 1785-1791.
17. New JP, Middleton RJ, Klebe B, et al. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice. Diabet Med 2007; 24(4): 364-369.
18. Coresh J, Astor BQ Green T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey. Am J Kidney Dis 2003; 41(1): 1-12.
19. Roderick PJ, Atkins RJ, Smeeth L, et al. Detecting chronic kidney disease in older people; what are the implications? Age Ageing 2008; 37(2): 179-186.
20. Ford I, Bezlyak V, Stott DJ, et al. Reduced glomerular rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis. PLoS Med 2009; 6(1): e16.
21. Van Bemmel T, Woittiez K, Blauw GJ, et al. Prospective study of the effect of blood pressure on renal function in old age: the Leiden 85-Plus Study. JAm Soc Nephrol 2006; 17(9): 2561-2566.
22. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J. Am Soc Nephrol 2005; 16(2): 489-495.